[HTML][HTML] Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Understanding vaccine-elicited protection against SARS-CoV-2 variants and other
sarbecoviruses is key for guiding public health policies. We show that a clinical stage …
sarbecoviruses is key for guiding public health policies. We show that a clinical stage …
[PDF][PDF] Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
AC Walls, MC Miranda, A Schafer, MN Pham… - Cell, 2021 - academia.edu
Understanding vaccine-elicited protection against SARS-CoV-2 variants and other
sarbecoviruses is key for guiding public health policies. We show that a clinical stage …
sarbecoviruses is key for guiding public health policies. We show that a clinical stage …
[引用][C] Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
AC Walls, MC Miranda, A Schäfer, MN Pham… - Cell, 2021 - cir.nii.ac.jp
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle
vaccines | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
vaccines | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
[HTML][HTML] Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
AC Walls, MC Miranda, A Schäfer, MN Pham… - Cell, 2021 - ncbi.nlm.nih.gov
Understanding vaccine-elicited protection against SARS-CoV-2 variants and other
sarbecoviruses is key for guiding public health policies. We show that a clinical stage …
sarbecoviruses is key for guiding public health policies. We show that a clinical stage …
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
A Walls, MC Miranda, A Schäfer, MN Pham, A Greaney… - Cell, 2021 - cdr.lib.unc.edu
Understanding vaccine-elicited protection against SARS-CoV-2 variants and other
sarbecoviruses is key for guiding public health policies. We show that a clinical stage …
sarbecoviruses is key for guiding public health policies. We show that a clinical stage …
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
AC Walls, MC Miranda, MN Pham, A Schäfer… - bioRxiv, 2021 - biorxiv.org
Understanding the ability of SARS-CoV-2 vaccine-elicited antibodies to neutralize and
protect against emerging variants of concern and other sarbecoviruses is key for guiding …
protect against emerging variants of concern and other sarbecoviruses is key for guiding …
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
AC Walls, MC Miranda, MN Pham, A Schaefer… - 2021 - pesquisa.bvsalud.org
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain
nanoparticle vaccines | PREPRINT-BIORXIV loading 1 2 3 +A A -A 3.Elicitation of broadly …
nanoparticle vaccines | PREPRINT-BIORXIV loading 1 2 3 +A A -A 3.Elicitation of broadly …
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
AC Walls, MC Miranda, A Schäfer, MN Pham… - Cell, 2021 - pubmed.ncbi.nlm.nih.gov
Understanding vaccine-elicited protection against SARS-CoV-2 variants and other
sarbecoviruses is key for guiding public health policies. We show that a clinical stage …
sarbecoviruses is key for guiding public health policies. We show that a clinical stage …
[HTML][HTML] Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
AC Walls, MC Miranda, A Schäfer, MN Pham… - Cell, 2021 - Elsevier
Understanding vaccine-elicited protection against SARS-CoV-2 variants and other
sarbecoviruses is key for guiding public health policies. We show that a clinical stage …
sarbecoviruses is key for guiding public health policies. We show that a clinical stage …
[HTML][HTML] Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
AC Walls, MC Miranda, MN Pham, A Schäfer… - 2021 - europepmc.org
Understanding the ability of SARS-CoV-2 vaccine-elicited antibodies to neutralize and
protect against emerging variants of concern and other sarbecoviruses is key for guiding …
protect against emerging variants of concern and other sarbecoviruses is key for guiding …